Enzymes
in the Fight Against Cancer.
By: Dr. William Wong, ND, PhD.
Cancer,
the very name alone scares most people. These
days man has a vast amount of information
on what things cause the disease, how
it progresses, it's growth rates vs.
age, which forms are faster spreading
than others but what we don't posses
is the answer as to how to stop it. I
won't touch on what I believe are the
business reasons why the disease has
such poor treatment rates in the US as
opposed to else where, this isn't the
forum for it. Suffice to say that
other countries have a better handle
on fighting the disease than we do and
lets look at one of the reasons why.
Neoplasm's
(cancers) are smart and cagey buggers. They
can hide and grow for a good spell undetected,
they don't need oxygen to live (at least
99.9% of them don't), and while you can
kill most all of it with special treatments
and surgery all it take's is for one
cell to survive to have the condition
grow back again. Many cancers are
hormonally driven, such as testicular
cancer in younger men or cancers of the
reproductive organs in middle aged and
older women. This provides
the perfect fuel as during those periods
of life certain hormones abound. A
cancer is built to survive. CA
(cancer) cells are covered with fibrin
(the same stuff scar tissue is made of). Then
as the cells glom together to form tumors
these growths themselves are armored
with fibrin. This thick protective
coating is designed to prevent the bodies'
own defenses (i.e. Natural Killer cells,
White blood cells or Oxygen) from getting
inside the cell or tumor and destroy
it. It is this same defense that
keeps chemotherapy out of the cells in
all but industrial strength doses. (Doses
that are just as likely to kill the patient
as the cancer). It is this same
defense that keeps out whatever natural
agent's patients may be using to combat
the disease.
Would
it not make sense to have something strip
away the outer fibrous wall of CA so
that whatever agents we are using as
medicine, whether natural or otherwise,
can actually get into the cell and do
their job? Sure as heck does? That
idea has made sense in Europe and Asia
for almost 30 years. There docs
have been throwing highly fibrinolytic
enzymes (scar tissue eating enzymes)
both in blends and as solo enzymes at
cancers outer coating and getting better
results with turning the tide that the
folks here in the States. So why
has something with a 30 year history
of proven worth and clinical application
not reached the shores of America yet? Good
question.
In truth,
there have been attempts to introduce
systemic enzymes into cancer therapy
here as far back as the 1970's. Dr.
William Kelly DDS, had an enzyme based
anti cancer therapy he used on pancreatic
cancer patients. For those not
familiar with that form of cancer the
survival rate from it was 0. Dr.
Kelly had a record of remission with
his patients of 80+%. (1). Not
possible thought the ivory towers of
establishment medicine. Also two major
hindrances kept popping up for Dr. Kelly,
first he was a dentist not an MD. Secondly
it was also not believed here in this
country that enzymes could be absorbed
orally. That kept many a doc from
even looking at Kelly's findings. (2,3).
SO they
sent a young medical intern, Dr. Nicholas
Gonzalez to investigate Kelly's claims
and debunk him. Far from proving
him a fraud the young MD found Kelly's
treatments worked and his recovery rate
was as he said. That did not settle
things. The story of Dr. Kelly's
persecution, the mysterious death of
his wife and his being run out of the
country is too long a tale to take up
here. Nuff said that his therapy
worked.
Concurrent
with those events, in Germany and Japan
enzymes were being used both singly and
in groups by orthodox medical researchers
to augment established therapy. It
was found that by introducing a strongly
fibrinolytic enzyme like chymotrypsin
or serrapeptase that anti cancer medications
penetrated the cancer cell easier. Therefore
lower dosages of chemotherapy could be
used and high levels of toxicity in the
patient could be avoided. Along
with that researchers found that the
enzymes seemed to reduce the side effects
of the chemotherapy and, definitely reduced
the debilitating muscle wasting that
chemo therapy produced in it's patients. (4,5,6)
In radiation
therapy patients, these doctors found
that taking systemic enzymes after treatments
reduced the fibrosis that grew in the
treated organs. Organs treated
with radiation become very hard filled
with scar tissue, which restricts the
organ and reduces its overall function. The
enzymes were found to prevent a good
bit of that scaring from occurring and
where it had already happened, the enzymes
reduced existing fibrosis. (7). The
use of orally administered systemic enzymes
to aid in the treatment of cancer was
embraced by these countries.
After
decades of resistance, systemic enzyme
therapy as an adjunct to overall cancer
treatment has finally gained a foothold
in America. Wholistic and
alternative cancer treatment centers
are using enzymes to assist in the fight
against the disease. Individual
oncologist's, realizing the clinical
advantage posed by these agents, are
now introducing them into the toolbox
of things one can do against the disease. No
less than the likes of the great Naturopathic
physician Dr. Michael Murray recommends
systemic enzyme use in his work "How
to Prevent and Treat Cancer With Natural
Medicine".
Now
here's the pitch: To
quote from Dr. Murray:" Serratia
peptidase exerts more powerful effects
than chymotrypsin and trypsin in all
of these applications". Serratia
peptidase is the same as serrapeptase. Remembering
that enzymes in blends exert a far greater
range and strength of actions than solo
enzymes, I believe that serrapeptase
based enzyme blends are the best systemic
enzymes to apply in the fight against
cancer. Nuff Said.
References:
1) Dr.
William Kelly's' book "One Answer
to Cancer" is available free as
a download on: http://www.drkelley.com/CANLIVER55.html
2) Moriya, N, Nakata M, Nakamura M, Takaoka
M, Iwasa S, Kato K, Kakinuma A. Intestinal
absorption of serrapeptase (TSP) in rats.
Biotechnol Appl Biochem. 1994; 20(Pt1):101-8.
3) Miyata, K. Intestinal absorption of
Serratia Peptidase. J Appl Biochem. 1980;2:111-16.
4) Rosanova, A.: The present stand of
enzyme therapy in the treatment of malignant
tumors. Arztl Praxis XVI 36, 1964,
1442-1444.
5) Konig, W.: Enzyme therapy in the treatment
of viral diseases and carcinoma. Erfahrungsheilk.
38, 1989, 455-459.
6) Desser, L., Ransberger, A.: Introduction
of tumor necrosis factor in human peripheral-blood
mononuclear cells by proteolytic enzymes. Oncology
47, 1990, 475.
7) Beaufort, E.: Reduction in the adverse
effects of radiation therapy with hydrolytic
enzymes. Therapeutikon 10, 1990,
577-580. |